MCM
IBBQ icon

MAI Capital Management’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

MAI Capital Management’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.4K Sell
840
-10
-1% -$291 ﹤0.01% 2677
2025
Q4 		$24.1K Sell
850
-400
-32% -$10.9K ﹤0.01% 2417
2025
Q3 		$30.4K Sell
1,250
-790
-39% -$18.2K ﹤0.01% 2205
2025
Q2 		$43.1K Sell
2,040
-50
-2% -$1.03K ﹤0.01% 1947
2025
Q1 		$44.3K Sell
2,090
-300
-13% -$6.67K ﹤0.01% 1808
2024
Q4 		$51.4K Buy
+2,390
New +$55.1K ﹤0.01% 1753

Other funds holding IBBQ

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
WG
WMS Group Folsom, Louisiana $68.8M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $743M AUM 28.33% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

MAI Capital Management's IBBQ Position: Q1 2026 in Review

MAI Capital Management reduced its Invesco NASDAQ Biotechnology ETF (IBBQ) stake by 1.2% in Q1 2026, selling an estimated $291 and leaving 840 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2677.

MAI Capital Management first reported a position in IBBQ in Q4 2024 and has held it in 6 quarters since. The position peaked at $51.4K in Q4 2024. 39 funds tracked by Wall St. Rank hold IBBQ as of Q1 2026.

  • MAI Capital Management held 840 shares of Invesco NASDAQ Biotechnology ETF worth $24.4K as of Q1 2026.
  • MAI Capital Management sold 10 Invesco NASDAQ Biotechnology ETF shares in Q1 2026, an estimated $291.
  • Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #2677 holding.
  • MAI Capital Management first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2024 and has held it in 6 quarters since.
  • MAI Capital Management's Invesco NASDAQ Biotechnology ETF position peaked at $51.4K in Q4 2024.
  • 39 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.